Metropolitan Life Insurance CO Zentalis Pharmaceuticals, Inc. Transaction History

Metropolitan Life Insurance CO

  • $281 Million
  • Q3 2024

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
BUY
$19.63 - $28.29 $13,799 - $19,887
703 Added 26.18%
3,388 $67,000
Q2 2023

Aug 10, 2023
BUY
$17.41 - $30.05 $2,837 - $4,898
163 Added 6.46%
2,685 $75,000
Q1 2023

May 15, 2023
SELL
$16.14 - $24.94 $4,938 - $7,631
-306 Reduced 10.82%
2,522 $43,000
Q4 2022

Jun 14, 2023
BUY
$18.07 - $25.6 $5,529 - $7,833
306 Added 12.13%
2,828 $57 Million
Q3 2022

Jun 14, 2023
BUY
$20.23 - $31.73 $6,190 - $9,709
306 Added 12.13%
2,828 $61.3 Million
Q3 2022

Mar 30, 2023
BUY
$20.23 - $31.73 $11,126 - $17,451
550 Added 24.14%
2,828 $61,000
Q3 2022

Nov 14, 2022
BUY
$20.23 - $31.73 $11,126 - $17,451
550 Added 24.14%
2,828 $61,000
Q2 2022

Jun 20, 2023
SELL
$17.91 - $52.25 $4,370 - $12,749
-244 Reduced 9.67%
2,278 $64,000
Q1 2022

Jun 20, 2023
SELL
$41.58 - $80.89 $10,145 - $19,737
-244 Reduced 9.67%
2,278 $105,000
Q1 2022

Mar 30, 2023
SELL
$41.58 - $80.89 $296,839 - $577,473
-7,139 Reduced 75.81%
2,278 $105,000
Q1 2022

May 12, 2022
SELL
$41.58 - $80.89 $296,839 - $577,473
-7,139 Reduced 75.81%
2,278 $105,000
Q4 2021

Jun 21, 2023
BUY
$66.92 - $84.79 $461,413 - $584,627
6,895 Added 273.39%
9,417 $791,000
Q3 2021

Jun 21, 2023
BUY
$46.83 - $73.5 $322,892 - $506,782
6,895 Added 273.39%
9,417 $627,000
Q3 2021

Mar 30, 2023
BUY
$46.83 - $73.5 $42,521 - $66,738
908 Added 10.67%
9,417 $627,000
Q3 2021

Nov 15, 2021
BUY
$46.83 - $73.5 $42,521 - $66,738
908 Added 10.67%
9,417 $628,000
Q2 2021

Jun 21, 2023
BUY
$37.41 - $62.25 $223,973 - $372,690
5,987 Added 237.39%
8,509 $452,000
Q2 2021

Mar 30, 2023
BUY
$37.41 - $62.25 $8,604 - $14,317
230 Added 2.78%
8,509 $452,000
Q2 2021

Aug 16, 2021
BUY
$37.41 - $62.25 $318,022 - $529,187
8,501 Added 106262.5%
8,509 $453,000
Q1 2021

Jun 26, 2023
BUY
$35.69 - $52.72 $205,467 - $303,509
5,757 Added 228.27%
8,279 $359 Million
Q1 2021

May 14, 2021
SELL
$35.69 - $52.72 $295,191 - $436,047
-8,271 Reduced 99.9%
8 $359,000
Q4 2020

Jun 22, 2023
BUY
$31.71 - $57.97 $182,554 - $333,733
5,757 Added 228.27%
8,279 $430,000
Q4 2020

Mar 30, 2023
BUY
$31.71 - $57.97 $151,383 - $276,748
4,774 Added 136.21%
8,279 $430,000
Q4 2020

Feb 16, 2021
BUY
$31.71 - $57.97 $151,383 - $276,748
4,774 Added 136.21%
8,279 $430,000
Q3 2020

Jun 26, 2023
BUY
$27.03 - $47.97 $26,570 - $47,154
983 Added 38.98%
3,505 $114,000
Q2 2020

Jun 26, 2023
BUY
$23.2 - $54.8 $22,805 - $53,868
983 Added 38.98%
3,505 $168,000
Q2 2020

Mar 30, 2023
BUY
$23.2 - $54.8 $15,706 - $37,099
677 Added 23.94%
3,505 $168,000
Q2 2020

Aug 14, 2020
BUY
$23.2 - $54.8 $81,316 - $192,074
3,505 New
3,505 $168,000

Others Institutions Holding ZNTL

# of Institutions
142
Shares Held
67.9M
Call Options Held
48.5K
Put Options Held
89.6K
View Full List

About Zentalis Pharmaceuticals, Inc.

ZNTL Quotes by TradingView
  • Ticker ZNTL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,983,600
  • Market Cap $166M
  • Description
  • Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers. Its lead product candidate includes the ZN-c3, an inhibitor of WEE1, a protein tyrosine kinase, which is in Phase 2 clinical trial for the treatment of advanced solid ...
More about ZNTL
Track This Portfolio

Track Metropolitan Life Insurance CO Portfolio

Follow Metropolitan Life Insurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email